Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma
Titel:
Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma
Auteur:
Khushman, Moh'd Dempsey, Naomi Cudris Maldonado, Jennifer Loaiza-Bonilla, Arturo Velez, Michel Carcas, Lauren Dammrich, Daniel Hurtado-Cordovi, Jorge Parajuli, Ritesh Pollack, Terri Harwood, Ana P. Macintyre, Jessica Tzeng, Ching-Wei D. Merchan, Jaime R. Restrepo, Maria H. Akunyili, Ikechukwu I. Ribeiro, Afonso Narayanan, Govindarajan Portelance, Lorraine Sleeman, Danny Levi, Joe U. Rocha Lima, Caio M.S. Hosein, Peter J.